Medication Competition Act

The Medication Competition Act requires the Food and Drug Administration to publish specific expiration dates for legal protections on biological drugs. This rule applies to both new drugs approved after the law passes and older drugs that received protection before the law was enacted. By making these timelines public, the bill aims to help generic drug makers know exactly when they can start selling their own versions of these medicines. The change does not alter the length of the protection periods themselves but increases transparency regarding when those periods end.